BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11939833)

  • 1. Sarcoidosis during combined interferon alfa and ribavirin therapy in 2 patients with chronic hepatitis C.
    Wendling J; Descamps V; Grossin M; Marcellin P; Le Bozec P; Belaich S; Crickx B
    Arch Dermatol; 2002 Apr; 138(4):546-7. PubMed ID: 11939833
    [No Abstract]   [Full Text] [Related]  

  • 2. Cutaneous sarcoidosis during interferon alfa and ribavirin treatment of hepatitis C virus infection: two cases.
    Cogrel O; Doutre MS; Marlière V; Beylot-Barry M; Couzigou P; Beylot C
    Br J Dermatol; 2002 Feb; 146(2):320-4. PubMed ID: 11903249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Papular Sarcoidosis of the Knees Following Treatment with Interferon Alpha and Ribavirin in a Woman with Hepatitis C.
    Monteagudo B; Grueiro MC; Vilas-Sueiro A; Campo-Cerecedo F
    Actas Dermosifiliogr (Engl Ed); 2019 Dec; 110(10):871-873. PubMed ID: 31387690
    [No Abstract]   [Full Text] [Related]  

  • 4. Cutaneous sarcoidosis associated with pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C.
    Rogers CJ; Romagosa R; Vincek V
    J Am Acad Dermatol; 2004 Apr; 50(4):649-50. PubMed ID: 15034524
    [No Abstract]   [Full Text] [Related]  

  • 5. [Probable cutaneous sarcoidosis associated with combined ribavirin and interferon-alpha therapy for chronic hepatitis C].
    Savoye G; Goria O; Herve S; Riachi G; Noblesse I; Bastien L; Courville P; Lerebours E
    Gastroenterol Clin Biol; 2000; 24(6-7):679. PubMed ID: 10962394
    [No Abstract]   [Full Text] [Related]  

  • 6. Adverse cutaneous reactions to interferon alfa-2b plus ribavirin therapy in patients with chronic hepatitis C virus.
    Manjón-Haces JA; Vázquez-López F; Gómez-Díez S; Hidalgo-García A; Pérez-Alvarez R; Soler-Sánchez T; Pérez-Oliva N
    Acta Derm Venereol; 2001; 81(3):223. PubMed ID: 11558891
    [No Abstract]   [Full Text] [Related]  

  • 7. Eczema-like lesions and disruption of therapy in patients treated with interferon-alfa and ribavirin for chronic hepatitis C: the value of an interdisciplinary assessment.
    Vázquez-López F; Manjón-Haces JA; Pérez-Alvarez R; Pérez-Oliva N
    Br J Dermatol; 2004 May; 150(5):1046-7; author reply 1047. PubMed ID: 15149535
    [No Abstract]   [Full Text] [Related]  

  • 8. High prevalence of cutaneous reactions to interferon alfa plus ribavirin combination therapy in patients with chronic hepatitis C virus.
    Sookoian S; Neglia V; Castaño G; Frider B; Kien MC; Chohuela E
    Arch Dermatol; 1999 Aug; 135(8):1000-1. PubMed ID: 10456365
    [No Abstract]   [Full Text] [Related]  

  • 9. Diffuse cutaneous eruption due to interferon alfa and ribavirin treatment of chronic hepatitis C.
    Savk E; Uslu G; Karaoğlu AO; Sendur N; Karaman G
    J Eur Acad Dermatol Venereol; 2005 May; 19(3):396-8. PubMed ID: 15857485
    [No Abstract]   [Full Text] [Related]  

  • 10. Meyerson's naevi induced by interferon alfa plus ribavirin combination therapy in hepatitis C infection.
    Conde-Taboada A; de la Torre C; Feal C; Mayo E; Gonzalez-Sixto B; Cruces MJ
    Br J Dermatol; 2005 Nov; 153(5):1070-2. PubMed ID: 16225630
    [No Abstract]   [Full Text] [Related]  

  • 11. Cutaneous side-effects of treatment of chronic hepatitis C by interferon alfa and ribavirin.
    Kerl K; Negro F; Lübbe J
    Br J Dermatol; 2003 Sep; 149(3):656. PubMed ID: 14511009
    [No Abstract]   [Full Text] [Related]  

  • 12. Meyerson's phenomenon induced by interferon-alfa plus ribavirin in hepatitis C infection.
    Girard C; Bessis D; Blatìre V; Guilhou JJ; Guillot B
    Br J Dermatol; 2005 Jan; 152(1):182-3. PubMed ID: 15656829
    [No Abstract]   [Full Text] [Related]  

  • 13. Cutaneous reactions to interferon and ribavirin.
    Chamberlain AJ; Poon E
    Intern Med J; 2004 Aug; 34(8):519. PubMed ID: 15317557
    [No Abstract]   [Full Text] [Related]  

  • 14. Pegylated interferon alfa-induced sarcoidosis: two sides of the same coin.
    Guilabert A; Bosch X; Julià M; Iranzo P; Mascaró JM
    Br J Dermatol; 2005 Feb; 152(2):377-9. PubMed ID: 15727663
    [No Abstract]   [Full Text] [Related]  

  • 15. [Generalized eczema secondary to combined treatment with peginterferon alfa-2a and ribavirin in a patient with chronic hepatitis from the hepatitis C virus].
    Ruiz de Casas A; García-Bravo B; Camacho F
    Actas Dermosifiliogr; 2005 Mar; 96(2):122-3. PubMed ID: 16476350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent antiphospholipid syndrome and cutaneous [corrected] sarcoidosis due to interferon alfa and ribavirin treatment for hepatitis C.
    Shinohara MM; Davis C; Olerud J
    J Drugs Dermatol; 2009 Sep; 8(9):870-2. PubMed ID: 19746680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cutaneous sarcoidosis during pegylated interferon alpha and ribavirin treatment of chronic hepatitis C--a case report].
    Honsová E; Sticová E; Sperl J
    Cesk Patol; 2007 Jan; 43(1):27-30. PubMed ID: 17370474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarcoidosis on the injection sites following treatment of interferon-alpha and ribavirin for hepatitis C.
    Chiang CH; Lai FJ
    J Formos Med Assoc; 2014 Dec; 113(12):981-2. PubMed ID: 25187070
    [No Abstract]   [Full Text] [Related]  

  • 19. [Sarcoïdose in patient with chronic hepatitis C treated with pegylated interferon].
    Moudden MK; Ziadi T; Al Bouzidi A; Ouarssani A; Hadri L; El Baaj M
    Rev Pneumol Clin; 2014 Dec; 70(6):362-5. PubMed ID: 25131364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of irreversible alopecia associated with ribavirin and peg-interferon therapy.
    Shafa S; Borum ML; Igiehon E
    Eur J Gastroenterol Hepatol; 2010 Jan; 22(1):122-3. PubMed ID: 19959941
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.